Addex Therapeutics Statistics

Total Valuation

ADXN has a market cap or net worth of $9.16 million. The enterprise value is $4.81 million.

Market Cap	9.16M
Enterprise Value	4.81M

Important Dates

The next confirmed earnings date is Monday, November 11, 2024, before market open.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

ADXN has 98.30 million shares outstanding. The number of shares has increased by 50.83% in one year.

Shares Outstanding	98.30M
Shares Change (YoY)	+50.83%
Shares Change (QoQ)	+72.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	34.24M

Valuation Ratios

The trailing PE ratio is 1.91.

PE Ratio	1.91
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1.00
EV / Sales	5.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.00.

Current Ratio	4.97
Quick Ratio	4.67
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-513.81

Financial Efficiency

Return on equity (ROE) is -126.29% and return on invested capital (ROIC) is -73.55%.

Return on Equity (ROE)	-126.29%
Return on Assets (ROA)	-61.71%
Return on Capital (ROIC)	-73.55%
Revenue Per Employee	$41,767
Profits Per Employee	$208,904
Employee Count	23
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +81.13% in the last 52 weeks. The beta is 1.98, so ADXN's price volatility has been higher than the market average.

Beta (5Y)	1.98
52-Week Price Change	+81.13%
50-Day Moving Average	10.28
200-Day Moving Average	10.53
Relative Strength Index (RSI)	55.57
Average Volume (20 Days)	24,316

Short Selling Information

Short Interest	9,886
Short Previous Month	9,605
Short % of Shares Out	1.18%
Short % of Float	n/a
Short Ratio (days to cover)	0.35

Income Statement

In the last 12 months, ADXN had revenue of $960,641 and earned $4.80 million in profits. Earnings per share was $0.05.

Revenue	960,641
Gross Profit	-6.80M
Operating Income	-12.47M
Pretax Income	-12.96M
Net Income	4.80M
EBITDA	-12.32M
EBIT	-12.47M
Earnings Per Share (EPS)	$0.05

Full Income Statement

Balance Sheet

The company has $4.22 million in cash and $35,813 in debt, giving a net cash position of $4.18 million or $0.04 per share.

Cash & Cash Equivalents	4.22M
Total Debt	35,813
Net Cash	4.18M
Net Cash Per Share	$0.04
Equity (Book Value)	14.08M
Book Value Per Share	0.14
Working Capital	4.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.71 million and capital expenditures -$2,095, giving a free cash flow of -$9.06 million.

Operating Cash Flow	-8.71M
Capital Expenditures	-2,095
Free Cash Flow	-9.06M
FCF Per Share	-$0.09

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,298.01%
Pretax Margin	-1,373.53%
Profit Margin	500.17%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-576.02%

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.83%
Shareholder Yield	-50.83%
Earnings Yield	52.47%
FCF Yield	-98.93%

Analyst Forecast

The average price target for ADXN is $30.00, which is 173.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	173.72%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 23, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Oct 23, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

ADXN has an Altman Z-Score of -32.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-32.87
Piotroski F-Score	2